Wang Yusu, Zong Ying, Chen Weijia, Diao Naichao, Zhao Quanmin, Jia Boyin, Zhang Miao, Li Jianming, Zhao Yan, He Zhongmei, Du Rui
College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
College of Animal Science and Technology, Jilin Agricultural University, Changchun 130118, China.
Biomolecules. 2025 Aug 4;15(8):1124. doi: 10.3390/biom15081124.
The combination of scaffold materials and bioactive factors is a promising strategy for promoting bone defect repair in tissue engineering. Previous studies have shown that osteoglycin (OGN) is highly expressed in the bone repair process using deer antler as an animal model of bone defects. It suggests that OGN may be a key active component involved in the bone repair process. The aim of this study was to investigate whether deer OGN (dOGN) could effectively promote bone regeneration. We successfully expressed dOGN using the pET30a system and evaluated its biological activity through cell proliferation and migration assays. At a concentration of 5 μg/mL, dOGN significantly promoted cell proliferation and migration. We then incorporated dOGN onto decellularized antler cancellous bone (DACB) scaffolds and assessed their osteogenic potential both in vitro and in vivo. The results indicated that dOGN loading enhanced cell proliferation, adhesion, and osteogenic activity. In vivo experiments confirmed that the dOGN-DACB scaffold significantly improved bone regeneration compared to DACB alone. This study demonstrates that dOGN-loaded DACB scaffolds hold great potential for clinical applications in treating critical-sized bone defects by mimicking the rapid regenerative properties of deer antlers.
支架材料与生物活性因子的组合是组织工程中促进骨缺损修复的一种有前景的策略。先前的研究表明,以鹿茸作为骨缺损动物模型,骨甘蛋白(OGN)在骨修复过程中高表达。这表明OGN可能是参与骨修复过程的关键活性成分。本研究的目的是探讨鹿源OGN(dOGN)是否能有效促进骨再生。我们使用pET30a系统成功表达了dOGN,并通过细胞增殖和迁移实验评估了其生物学活性。在浓度为5μg/mL时,dOGN显著促进细胞增殖和迁移。然后,我们将dOGN整合到脱细胞鹿茸松质骨(DACB)支架上,并在体外和体内评估了它们的成骨潜力。结果表明,负载dOGN可增强细胞增殖、黏附和成骨活性。体内实验证实,与单独的DACB相比,dOGN-DACB支架显著改善了骨再生。本研究表明,通过模拟鹿茸的快速再生特性,负载dOGN的DACB支架在治疗临界尺寸骨缺损的临床应用中具有巨大潜力。